H.R. 2450 · 119th Congress

Prescription Drug Transparency and Affordability Act

Stage
In committee
Sponsor
Kristen McDonald Rivet
Introduced
2025-03-27
Latest action
2025-03-27 · Introduced in House

Action history

  1. 2025-03-27Introduced in House
  2. 2025-03-27Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  3. 2025-03-27Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. 2025-03-27Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.